Related Experiment Videos
Primary hyperparathyroidism, pregnancy, and neonatal hypocalcemia
Surgery
|October 1, 1984
Summary
Maternal primary hyperparathyroidism causes fetal hypercalcemia, suppressing fetal parathyroid function. This leads to neonatal hypocalcemia after birth, which can be prevented by maternal parathyroidectomy during pregnancy.
Area of Science:
- Endocrinology
- Obstetrics
- Perinatology
Background:
- Primary hyperparathyroidism during pregnancy is linked to severe fetal complications like neonatal tetany.
- Neonatal hypocalcemia is a significant risk in infants born to mothers with hyperparathyroidism.
Purpose of the Study:
- To investigate the pathophysiology of neonatal hypocalcemia in the context of maternal primary hyperparathyroidism.
- To elucidate transplacental calcium dynamics and hormone transfer during pregnancy.
Main Methods:
- Studied calcium ion and hormone transfer across the placenta in pregnant ewes and their fetuses.
- Utilized hysterotomy to access fetal lambs for dynamic studies during the last trimester.
Main Results:
- Calcium ions transfer rapidly across the placenta.
- The placenta effectively blocks the passage of maternal parathyroid hormone and calcitonin to the fetus.
- Maternal hypercalcemia leads to fetal hypercalcemia, suppressing fetal parathyroid gland function.
Conclusions:
- Maternal hypercalcemia in primary hyperparathyroidism causes fetal hypercalcemia and suppressed fetal parathyroid function.
- Interruption of maternal calcium supply post-birth precipitates neonatal hypocalcemia.
- Maternal parathyroidectomy, ideally in the second trimester, can prevent this cycle and ensure fetal calcium homeostasis.